⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLLS News
Cellectis S.A. American Depositary Shares
Securities Fraud Investigation Into Cellectis S.A. (CLLS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
businesswire.com
CLLS
Cellectis S.A. (CLLS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
businesswire.com
CLLS
Securities Fraud Investigation Into Cellectis S.A. (CLLS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
businesswire.com
CLLS
Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company
globenewswire.com
CLLS
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
globenewswire.com
CLLS
Cellectis Announces Participation in Upcoming Investor Conferences
globenewswire.com
CLLS
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Grow Significantly at a CAGR of 6.8% During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Pipeline | DelveInsight
prnewswire.com
CLLS
AUTL
FATE
GILD
NVS
Cellectis Reports Financial Results for the Second Quarter 2026
globenewswire.com
CLLS
Cellectis Reports Financial Results for the Second Quarter 2026
globenewswire.com
CLLS
Cellectis to Report Second Quarter Financial Results on August 6, 2026
globenewswire.com
CLLS